Refractory B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB02379 | Beta-D-Glucose | 2 | Recruiting | 1 |
| DB00958 | Carboplatin | 2 | Recruiting | 1 |
| DB00531 | Cyclophosphamide | 2 | Recruiting | 1 |
| DB00773 | Etoposide | 2 | Recruiting | 1 |
| DB01181 | Ifosfamide | 2 | Recruiting | 1 |
| DB00480 | Lenalidomide | 2 | Recruiting | 1 |
| DB15044 | Tafasitamab | 2 | Recruiting | 1 |